HQL News and Press, TeklaLife Sciences Investors From 08/30/23

Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special meetings of shareholders (“Special Meetings”) were a...

2023-08-15 10:57:28 ET Tekla Life Sciences ( NYSE: HQL ) declares $0.32/share quarterly dividend , in line with previous. Forward yield 9.56% Payable Sept. 29; for shareholders of record Aug. 25; ex-div Aug. 24. See HQL Dividend Scorecard, Yield Chart, & ...

Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of shareholders on August 14, 2023 (“Special Meetings”...

2023-06-29 08:06:53 ET Summary Tekla Life Sciences Investors is a closed-ended equity fund that primarily invests in the life sciences sector, with a heavy focus on biotech and pharmaceuticals. The fund's dividend history has been stable over the last 10 years, ranging from $1.16 ...

PHILADELPHIA, PA / ACCESSWIRE / June 20, 2023 / abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in B...

Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management. 1 Under the propos...

2023-06-17 09:00:00 ET Summary Retirees, by the very definition of retirement, need to be financially independent. However, even for folks who are several years away from retirement, it can offer great benefits. We will go over our strategy as to how a diversified income and growt...

2023-05-15 11:22:40 ET Tekla Life Sciences ( NYSE: HQL ) declares $0.32/share quarterly dividend , -3% decrease from prior dividend of $0.33. Forward yield 9.15% Payable June 30; for shareholders of record May 25; ex-div May 24. See HQL Dividend Scorecard...

2023-03-08 03:27:02 ET Summary HQL focuses on the life sciences industry with a 74% allocation to biotechnology stocks. It pays a 2% quarterly managed distribution. The boom-bust nature of biotech stocks may not be suitable for a steady managed distribution strategy as it unde...

2023-03-05 07:56:14 ET Summary The HQH fund aims to provide high total returns through investments in the healthcare industry. HQH has a high allocation to risky biotech stocks and private investments. The fund pays a 2% of NAV quarterly distribution. However, HQH has under-earned...